Winton Group LTD Trevena Inc Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$1.11 - $1.7 $69,487 - $106,421	-62,601 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$1.46 - $2.25 $5,496 - $8,471	3,765 Added 6.4%	62,601 $106,000
Q1 2021 Jul 21, 2021	BUY	$1.77 - $2.93 $2,173 - $3,598	1,228 Added 2.13%	58,836 $105,000
Q4 2020 Feb 12, 2021	SELL	$2.13 - $3.26 $761,607 - $1.17 Million	-357,562 Reduced 86.12%	57,608 $123,000
Q3 2020 Oct 30, 2020	SELL	$1.53 - $3.13 $391,041 - $799,974	-255,583 Reduced 38.1%	415,170 $1.24 Million
Q2 2020 Aug 05, 2020	BUY	$0.48 - $1.75 $32,898 - $119,941	68,538 Added 11.38%	670,753 $1.01 Million
Q1 2020 May 11, 2020	BUY	$0.56 - $0.97 $39,026 - $67,600	69,691 Added 13.09%	602,215 $341,000
Q4 2019 Feb 13, 2020	SELL	$0.62 - $1.06 $104,457 - $178,588	-168,480 Reduced 24.03%	532,524 $448,000
Q3 2019 Nov 08, 2019	BUY	$0.81 - $1.06 $567,813 - $743,064	701,004 New	701,004 $678,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.